New drug for smallpox & monkeypox enters human testing
NCT ID NCT07377175
Summary
This is an early-stage study to check if a new drug called BSY001 is safe for people and how it moves through the body. Healthy volunteers will receive either the drug or a placebo injection, first as a single dose and then as multiple doses over two weeks. The main goal is to understand the drug's safety profile and how it behaves in healthy people before testing it in patients with poxvirus infections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MONKEYPOX are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shulan (Hangzhou) Hospital
RECRUITINGHangzhou, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.